NCT06690970View on ClinicalTrials.gov

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
PSMA-related DiseaseProstate CancerPositron Emission TomographyMetastasisFAP
Interventions
DIAGNOSTIC_TEST

68Ga/18F-PSMA/PSFA

Each subject receive a single intravenous injection of 68Ga/18F-PSMA/PSFA, and undergo PET/CT imaging within the specificed time.

Trial Locations (2)

230000

RECRUITING

The First Affiliated Hospital of University of Science and Technology of China, Hefei

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Tianjin Medical University

OTHER